Services

Header

Header

Header

Site-Specific Peptide Modification

Install labels, affinity tags, reactive handles, crosslinkers, lipids, PEG spacers, and functional payloads at a defined peptide terminus or side chain with sequence-aware chemistry and orthogonal protection strategies.

N-Terminal C-Terminal Lysine-Selective Cysteine-Selective Unnatural Amino Acids Dual Modification

Place the right chemistry at the right residue

Site-specific peptide modification gives precise control over where a functional group is installed. Defined placement can preserve a binding epitope, orient a peptide on a surface, separate a reporter from an active sequence, or create a reproducible conjugation product.

The synthesis route depends on residue availability, protecting-group orthogonality, modification stability, payload size, and whether installation is best performed during solid-phase synthesis or after purification.

01
Position

Choose a terminus or side chain away from critical activity.

02
Orthogonality

Protect non-targeted reactive groups during installation.

03
Compatibility

Match chemistry to sequence, payload, and cleavage conditions.

04
Verification

Confirm the final modified construct, not only the precursor.

Site-specific peptide engineering map A peptide backbone with highlighted N-terminal, C-terminal, lysine, cysteine, and unnatural amino acid modification sites connected to representative payload classes. DEFINED SITE · ORTHOGONAL CHEMISTRY · VERIFIED PRODUCT N-TERM α-amine LYS ε-amine CYS thiol C-TERM acid / amide UNNATURAL AMINO ACID azide · alkyne · tetrazine · TCO SITE SELECTION • preserve active epitope • avoid steric interference • reserve one reactive site PAYLOADS Dye Biotin PEG / Drug POSITION PROTECTION LIGATION

Design logic: select the least disruptive site, isolate it through orthogonal protection or an engineered handle, install the payload, and verify the complete modified peptide analytically.

Choose a defined site by chemistry and biological purpose

Each strategy balances accessibility, selectivity, synthetic practicality, and preservation of peptide function.

01
N

Terminal Modification

Use the N- or C-terminus for directional labeling, immobilization, capping, or conjugation when terminal placement does not disrupt activity.

02
K

Lysine-Selective

Apply orthogonal side-chain protection to modify one selected lysine even when additional lysines are present.

03
C

Cysteine-Selective

Use thiol chemistry for efficient post-synthetic attachment, provided disulfides and other cysteines are controlled.

04
X

Unnatural Amino Acid Handle

Introduce azide, alkyne, tetrazine, TCO, diazirine, or other orthogonal functionality at an exact internal position.

Search site-specific peptide modifications by residue or handle

Filter by modification family and search by code, site, installation route, or application. Final route selection requires sequence-specific feasibility review.

0 Entries
Modifier Code Family Defined Site Installation Typical Application

Technical note: Site selectivity depends on the complete sequence, protecting-group strategy, reagent stability, and reaction order. Final structure and modification position are confirmed during project review.

Plan orthogonal modifications within one peptide

Select one family for a fully expanded technical datasheet, or compare two or more families in an aligned multi-column view.

Select modification families

Choose one site for a detailed view or combine sites to compare modification options, chemistries, applications, and design constraints.

0 selected

Select a modification family to begin

Choose one site to review common modifications, compatible chemistries, applications, and design considerations. Add more sites to evaluate an orthogonal multi-modification design.

Expanded single-site view
Planning principle: reserve each target site with orthogonal protection, install stable groups during SPPS, and perform sensitive or bulky conjugations after purification.

Six questions that determine the best modification route

Use these design checkpoints before choosing a residue, handle, or conjugation method.

01

Where is activity located?

Avoid modifying residues that form the binding epitope, cleavage site, catalytic region, or required conformation.

02

Which site is unique?

A unique terminus or cysteine may simplify the route; repeated residues often require orthogonal protection.

03

When should installation occur?

Stable small groups may be incorporated during SPPS, while dyes and bulky payloads are often added afterward.

04

Does the payload need spacing?

Ahx or defined PEG spacers can reduce steric interference and improve accessibility.

05

Are chemistries orthogonal?

Dual modification requires handles and deprotection conditions that do not react with one another.

06

How will the site be verified?

Plan analytical confirmation appropriate to the product complexity and intended application.

Recommended starting point: when the natural sequence lacks a unique reactive site, incorporate an unnatural amino acid with an orthogonal handle rather than forcing a poorly selective conjugation.

From site selection to final release testing

Modification chemistry, peptide synthesis, purification, and analytical confirmation are planned as one integrated process.

01

Sequence Review

Map reactive residues, active regions, liabilities, and candidate attachment sites.

02

Site & Handle Selection

Choose the defined terminus, residue, or unnatural amino acid handle.

03

Protection Strategy

Plan orthogonal protecting groups and the order of deprotection.

04

Peptide Synthesis

Assemble the sequence with site-specific building blocks or reserved handles.

05

Selective Modification

Install the label, tag, spacer, lipid, or payload at the designated site.

06

Purification & QC

Purify and confirm identity, purity, and project-specific attributes.

Need help choosing the correct modification site?

Share your peptide sequence, desired modification, exact or preferred attachment position, payload or conjugation partner, intended application, and analytical requirements. Our scientists can evaluate residue accessibility, protecting-group strategy, reaction order, synthetic risk, purification complexity, and alternative routes before manufacturing begins.

Before You Submit Your Project

  • Complete peptide sequence
  • Exact or preferred modification site
  • Functional group, label, or payload
  • Required spacer or linker
  • Quantity, purity, and formulation
  • Intended assay or downstream conjugation
  • Relevant structure or literature reference

How We Evaluate Your Design

We review site uniqueness, sequence reactivity, orthogonal protection, payload stability, installation timing, purification behavior, and analytical confirmation. When a requested site is impractical, we explain the limitation and propose a more selective alternative.

Quality Systems & Manufacturing Support

QMS

ISO-Supported Site-Specific Peptide Manufacturing

Site-specific peptide modification projects are supported by controlled synthesis, orthogonal protection strategies, selective conjugation, purification, analytical characterization, documentation, traceability, and project-specific packaging from research through scale-up.

Certified Quality SystemsISO 9001:2015, ISO 13485:2016, and ISO 14001-supported operations.
Advanced Peptide ChemistryOrthogonal protection, selective deprotection, unnatural amino acid incorporation, and post-synthetic conjugation.
Analytical CharacterizationAnalytical HPLC or UPLC, LC-MS, optional HRMS, and project-specific testing.
Flexible ManufacturingCustom purification, formulation, documentation, and research-to-production scale support.

Site-Specific Peptide Modification FAQ

FAQ

What does site-specific peptide modification mean?
It means installing a defined functional group at one predetermined residue or terminus rather than modifying multiple available sites indiscriminately.
Which peptide positions can be modified selectively?
Common sites include the N-terminus, C-terminus, lysine, cysteine, serine, threonine, tyrosine, aspartate, glutamate, and incorporated unnatural amino acids.
How is a single lysine modified when several lysines are present?
Orthogonal side-chain protecting groups and sequence-specific synthesis planning allow one selected lysine to be exposed and modified while the others remain protected.
Is cysteine always the best site for conjugation?
Cysteine is highly useful because thiol chemistry is selective, but it may not be ideal when the peptide contains essential disulfides, multiple cysteines, or oxidation-sensitive sequences.
Can site-specific modification be performed after peptide purification?
Yes. Post-synthetic modification is often preferred for dyes, bulky payloads, reactive handles, and chemistries that may not tolerate cleavage conditions.
Can two different modifications be placed at two defined sites?
Yes. Dual or multifunctional peptides can be produced using orthogonal protecting groups and mutually compatible conjugation chemistries.
How do you confirm the modification site?
Mass spectrometry and analytical HPLC confirm identity and purity. Depending on complexity, tandem MS, enzymatic mapping, amino acid analysis, or orthogonal analytical methods may be recommended.
Can native peptide activity be preserved after modification?
Often yes, when the site and spacer are selected away from the active or binding region. Functional preservation cannot be assumed and should be evaluated in the intended assay.
Can site-specific handles be incorporated into cyclic or stapled peptides?
Yes, provided the modification does not compete with cyclization, stapling, or disulfide formation and the protecting-group strategy remains orthogonal.
What information is needed for a feasibility review?
Provide the sequence, exact modification site, desired functional group or payload, intended application, quantity, purity, formulation, and any relevant assay or literature constraints.

Recommended Reading

Selected literature supporting chemoselective ligation, cysteine and lysine modification, bioorthogonal chemistry, and precision peptide conjugation.

  1. Dawson PE, Muir TW, Clark-Lewis I, Kent SBH. Synthesis of proteins by native chemical ligation. Science. 1994;266:776–779.
  2. Sletten EM, Bertozzi CR. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angewandte Chemie International Edition. 2009;48:6974–6998.
  3. Spicer CD, Davis BG. Selective chemical protein modification. Nature Communications. 2014;5:4740.
  4. Koniev O, Wagner A. Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation. Chemical Society Reviews. 2015;44:5495–5551.
  5. Hoyt EA, Cal PMSD, Oliveira BL, Bernardes GJL. Contemporary approaches to site-selective protein modification. Nature Reviews Chemistry. 2019;3:147–171.

Scientific note: A chemically selective reaction is not automatically site-specific. True site control requires a unique reactive site, orthogonal protection, an engineered handle, or a synthesis strategy that differentiates one residue from all others.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.